Skyward Analytics

What Skyward Analytics does

Skyward Analytics Private Limited is a boutique consultancy founded in 2017 and headquartered in Gurugram, Haryana, India. The firm specializes exclusively in Health Economics and Outcomes Research (HEOR), pricing, and market access, delivering seven integrated service lines: HTA submissions, health economic modelling, literature reviews, meta-analysis (including NMA and MAIC/STC), scientific and value communications, real-world evidence studies, and strategic consulting. Its primary customers are pharmaceutical companies, medical device manufacturers, and midsize to large HEOR consultancies that require evidence generation, cost-effectiveness analysis, and reimbursement support across global markets. Service delivery spans eight countries across four continents — Australia, Singapore, India, UAE, UK, Japan, Germany, and the USA — with active conference presence at ISPOR, World EPA Congress, ASCO, HTAi, and the Global Evidence Summit.

The underlying technology stack centers on statistical analysis in R and SAS, dashboard development in R Shiny, and advanced modelling techniques including Markov models, decision trees, partition survival models, discrete event simulation, and microsimulation. The firm has begun embedding third-party LLMs (GPT-3.5 Turbo via the EasySLR platform) into systematic literature review workflows and has published peer-reviewed research benchmarking AI-assisted screening. Real-world evidence work draws on registries, electronic health records, medical claims, and survey data, with medical chart review and disease registry analysis delivered as standalone offerings.

Skyward Analytics is a privately held, founder-led company with no disclosed external funding, parent, or institutional investors. The 13-person team is led by Co-founder and CEO Hemant Rathi, with Team Lead Amit Gupta (economic modelling) and Senior Manager Surabhi Aggarwal (systematic reviews) heading delivery. Revenue is generated through project-based, multi-year professional services engagements sold primarily via direct enterprise sales, supplemented by a channel partnership with Lucid Health Consulting for the Australian market and advisory support from former Novartis HEOR/RWE executive Skip Olson in the US. Pricing is quote-based, not publicly disclosed, and engagement models are customized to client scope, complexity, and timeline.

Name

Skyward Analytics

Legal name

Skyward Analytics Private Limited

Website

https://skywardanalytics.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Skyward Analytics is a boutique India-based HEOR consultancy founded in 2017. It serves pharmaceutical companies, medical device manufacturers, and consulting firms globally with health technology assessment submissions, economic modelling, meta-analysis, literature reviews, and real-world evidence services.

Ownership category

akta.pro rank

Product category

HEOR Consulting

NAICS

Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro industry

PRIMARYHLAGAOAN

Market Access, Pricing & Reimbursement (Evidence Generation) FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• HEOR consulting
• HTA submissions
• Health economic modelling
• Real-world evidence
• Systematic literature reviews

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. HEOR Consulting Services: Project-based consulting engagements for pharmaceutical companies, medical device manufacturers, and healthcare consultancies. Services include HTA submissions, health economic modelling, literature reviews, meta-analysis, real-world evidence studies, scientific communications, and strategic consulting. Revenue is generated through professional services fees for deliverable-based or retainer-based engagements.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

Skyward Analytics is a boutique consultancy that delivers Health Economics and Outcomes Research (HEOR) professional services to pharmaceutical companies, medical device manufacturers, and HEOR consultancies. Its core service offerings include Health Technology Assessment (HTA) submission dossiers, health economic modelling (cost-effectiveness, cost-utility, budget impact, Markov, DES, microsimulation), systematic and targeted literature reviews, network meta-analysis, real-world evidence studies from registries/EHRs/claims data, scientific and value communications, and strategic market access consulting.

Product overview

Skyward Analytics is a boutique HEOR consultancy offering a comprehensive suite of analytics services for the healthcare industry. The company provides seven interconnected service offerings: HTA Submissions for regulatory dossier preparation; Health Economic Modelling for cost-effectiveness and budget impact analysis; Literature Reviews including systematic and targeted reviews; Meta Analysis for statistical synthesis and network meta-analysis; Scientific and Value Communications for strategic messaging; Real World Evidence studies leveraging real-world data; and Strategic Consulting for market access. Together, these services form an integrated approach to supporting pharmaceutical companies and medical device manufacturers in demonstrating product value, securing reimbursement, and achieving market access across global healthcare markets.

Differentiator

Problem solved

Functional benefit

Products and services

• HTA Submissions Comprehensive Health Technology Assessment (HTA) dossier preparation and submission services for pharmaceutical companies and midsize to large consultancies, including evidence synthesis, cost-effectiveness analysis, and value demonstration aligned with local regulatory requirements at various stages of HTA submission.
• Health Economic Modelling Specialized economic modelling services including cost-effectiveness models, cost-utility models (QALYs), cost-minimization analysis, cost-benefit analysis, and budget impact models using advanced approaches such as Markov models, decision tree models, partition survival models, discrete event simulation (DES), and microsimulation, tailored for healthcare market access and reimbursement.
• Literature Reviews Systematic literature reviews (SLR), targeted literature reviews (TLR), rapid reviews, and real-world data landscape analyses covering clinical, epidemiological, humanistic, and economic domains to identify pertinent evidence related to the decision problem, leveraging AI-assisted workflows via the EasySLR platform and LLM technology.
• Meta Analysis Advanced statistical meta-analysis services combining results from multiple studies to enhance understanding and inform decision-making, including direct meta-analysis, indirect treatment comparisons, network meta-analysis (NMA), meta-regression, and population-adjusted methods (MAIC/STC) for heterogeneous patient populations.
• Scientific and Value Communications Strategic communication services that clearly convey complex scientific information and demonstrate the value of products to stakeholders for informed decision-making, including global value dossiers, white papers, manuscripts for peer-reviewed journals, conference materials, and interactive dashboards.
• Real World Evidence Real-world studies using real-world data (RWD) to evaluate treatment effectiveness and safety in everyday healthcare settings, including analysis of registries, electronic health records (EHRs), medical claims data, and survey data integration, with medical chart reviews, disease and product registries analysis, EHR data mining, and data visualization and reporting services.
• Strategic Consulting Market access strategy consulting, pricing strategies, stakeholder engagement planning, and HEOR-powered insights for pharmaceutical companies and medical device manufacturers to optimize market access and reimbursement outcomes.

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Lucid Health ConsultingcoreChannel Partner/ Reseller/ DistributorLucid Health Consulting is Skyward Analytics's designated go-to partner for the Australian market. With over 75 years of combined experience in health economics, commercial and health technology assessments, stakeholder management, and full service requirements for optimizing and gaining market access, Lucid Health Consulting provides local expertise and client relationships in Australia while Skyward Analytics delivers the technical HEOR expertise.
• Skip OlsonminorStrategic or Co-development PartnerSkip Olson is an extended partner with over 30 years of pharmaceutical industry experience spanning different roles. After graduating from Harvard, he spent nearly a decade in Biostatistics roles followed with over two decades at the Novartis HEOR/RWE team. He serves as a key thought leader in the overall HEOR and RWE space, contributing expertise and industry connections for business development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Parexel International: Parexel is a top global CRO with integrated HEOR, market access, and RWE consulting capabilities; it is a broader-incumbent competitor bidding for the same pharma HTA, modelling, and evidence generation budgets as Skyward.
• Charles River Associates (CRA Life Sciences): CRA's Life Sciences practice provides HEOR, pricing, and market access consulting alongside broader management consulting; it competes with Skyward on economic modelling, pricing strategy, and value communication engagements for biopharma.
• IQVIA (HEOR / Real World Solutions): IQVIA operates one of the largest global HEOR and RWE practices alongside its CRO and commercial businesses; it is a broad incumbent whose HEOR offering competes with Skyward across modelling, evidence synthesis, and HTA submissions.
• Trinity Life Sciences: Trinity Life Sciences provides integrated evidence, access, pricing, and HEOR-adjacent strategy services to biopharma; it competes with Skyward in the economic evidence, value communication, and market access advisory space.

Direct peers

• RTI Health Solutions: RTI Health Solutions is a non-profit-affiliated HEOR and patient-centered outcomes research consultancy providing health economics, epidemiology, and HTA evidence generation; it competes head-to-head with Skyward for payer-relevant evidence development projects.
• Evidera (PPD, Thermo Fisher): Evidera is one of the largest dedicated HEOR, RWE, and market access consulting firms globally; it competes directly with Skyward Analytics for HTA dossiers, economic modelling, systematic reviews, and value communications work for pharma and medtech clients.
• Putnam Associates: Putnam Associates is a boutique pharma strategy consultancy focused on market access, pricing, and HEOR evidence development; it is comparable in boutique scale and HEOR/market access focus, serving similar mid-to-large biopharma clients.
• Pharmerit International (OPEN Health): Pharmerit is a boutique-to-mid-market HEOR and market access consultancy delivering modelling, evidence synthesis, and HTA support; it is one of the closest analogs in scale and service mix to Skyward Analytics.
• Xcenda (Cencora): Xcenda is a focused market access, HTA, and HEOR consultancy embedded in a larger pharmaceutical services organization; it competes directly with Skyward on payer evidence, AMCP dossiers, and value communications engagements.
• PRECISIONheor (Precision Medicine Group): PRECISIONheor is a specialist HEOR and market access consultancy offering health economics modelling, meta-analysis, and HTA submission support; it directly overlaps with Skyward's economic modelling, NMA/MAIC, and dossier services targeting pharma and medical device sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SkywardAnalytic
• Facebookfacebook.com/SkywardAnalytics
• LinkedInlinkedin.com/company/skyward-analytics-private-limited
• Instagraminstagram.com/skywardanalytics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skyward Analytics